Pooled results from 32 randomised trials in 5174 adults with chronic pain show non-inhaled medical cannabis gives a small improvement in pain relief, with 10% more patients reaching a meaningful reduction than on placebo, plus very small gains in physical functioning and sleep quality. It also raised the risk of transient side effects including dizziness, drowsiness, nausea, vomiting and impaired attention.
What it shows: About as solid as pain evidence gets: results pooled from 32 trials in 5174 adults, rated moderate to high certainty. The benefits are genuinely small though, follow-up lasted at most 5.5 months, and dizziness became far more common in trials running 3 months or longer.Meta-analysis · BMJ